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Introduction
How cell size is controlled and maintained during successive 
rounds of cell divisions is a question that has long fascinated cell 
biologists. Cell size is a key feature for the proper organization 
and function of tissues and organs in multicellular organisms, or 
for survival and competitive fitness in unicellular microorgan-
isms.1,2 Cell size control requires the precise coordination of cell 
growth with cell division. In microorganisms, evidence for such 
coordination has been known for a long time. In animal cells, 
analysis of cell size control has been slowed by technical limita-
tions. Recently, however, measurements of growth in human cell 
lines using microfluidic devices or on fixed steady-state popula-
tions with help of mathematical modeling, revealed regulatory 
events at the G
1
/S transition, decreasing cell size variation.3-5
In the fission yeast Schizosaccharomyces pombe, a rod-shaped 
single-cell eukaryote that exhibits stereotyped patterns of growth 
by cell tip extension and division by medial cleavage, direct evi-
dence for cell size control has existed since the 1970s, when it was 
shown that cells rapidly re-establish their normal length upon 
recovery from a transient cell cycle block.6 In this organism, one 
major homeostatic mechanism operates at the G
2
/M transition, 
when cells can adjust the time spent in G
2
 to divide only when 
a specific cell size has been reached.7,8 This transition is driven 
by CDK1, whose activation timing is dictated by the balance 
between the inhibitory Wee1 kinase and the activating Cdc25 
phosphatase.
We and others proposed a cell size-sensing mechanism, where 
cells geometrically monitor their length to control cell divi-
sion.9,10 This relies on the DYRK-family kinase, Pom1, which 
negatively regulates its substrate, the SAD-like kinase Cdr2. In 
turn, Cdr2 functions in a negative regulatory cascade to inhibit 
Wee1.11,12 Cdr2 assembles into cortical clusters, or nodes, at mid-
cell,13 which contain several additional components, including 
the Wee1-inhibitory kinase Cdr1/Nim114-16 and Wee1 itself.10,17 
By contrast, Pom1 forms concentration gradients from cell poles, 
associating with the plasma membrane in a phosphorylation-
regulated manner.18 Buffering mechanisms have further been 
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Where and when cells divide are fundamental questions. In rod-shaped fission yeast cells, the DYRK-family kinase 
pom1 is organized in concentration gradients from cell poles and controls cell division timing and positioning. pom1 
gradients restrict to mid-cell the SAD-like kinase Cdr2, which recruits Mid1/Anillin for medial division. pom1 also delays 
mitotic commitment through Cdr2, which inhibits Wee1. Here, we describe quantitatively the distributions of cortical 
pom1 and Cdr2. these reveal low profile overlap contrasting with previous whole-cell measurements and Cdr2 levels 
increase with cell elongation, raising the possibility that pom1 regulates mitotic commitment by controlling Cdr2 medial 
levels. However, we show that distinct thresholds of pom1 activity define the timing and positioning of division. three 
conditions—a separation-of-function pom1 allele, partial downregulation of pom1 activity, and haploinsufficiency in 
diploid cells—yield cells that divide early, similar to pom1 deletion, but medially, like wild-type cells. In these cells, Cdr2 
is localized correctly at mid-cell. Further, Cdr2 overexpression promotes precocious mitosis only in absence of pom1. 
thus, pom1 inhibits Cdr2 for mitotic commitment independently of regulating its localization or cortical levels. Indeed, 
we show pom1 restricts Cdr2 activity through phosphorylation of a C-terminal self-inhibitory tail. In summary, our results 
demonstrate that distinct levels in pom1 gradients delineate a medial Cdr2 domain, for cell division placement, and con-
trol its activity, for mitotic commitment.
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proposed to reduce noise in these gradients.19 Measurements of 
Pom1 distribution over the entire cell volume suggested that cell 
elongation, by driving the gradients’ sources at cell poles apart, 
leads to Pom1 concentration decrease at mid-cell.9,10 In the pro-
posed model, Pom1 negatively regulates Cdr2 in short cells, 
preventing mitotic entry until a critical size has been reached. 
Whether Pom1 strongly serves as length sensor has, however, 
been put into question by recent data showing that pom1Δ cells 
are able to adjust their length after perturbation.20
Intriguingly, Pom1 and Cdr2 not only regulate division tim-
ing, but also division site positioning. Here, Cdr2 plays a posi-
tive role in defining a medial division plane, as it recruits to the 
medial cortex Mid1/Anillin, which, in turn, controls the assem-
bly of the contractile ring.21,22 This pathway works in parallel to a 
second pathway promoting medial division by coupling division 
plane position to nuclear position via nuclear shuttling of Mid121 
(see also refs. 23–25 for reviews). By contrast, Pom1 plays a nega-
tive role in division site positioning, preventing division near cell 
poles. This occurs largely through regulation of Cdr2 localiza-
tion: in pom1Δ cells, which are also defective for bipolar growth, 
Cdr2 nodes are no longer restricted to mid-cell and invade the 
non-growing cell tip,9,10 with the division site bisecting the Cdr2–
Mid1 domain.26,27 Forced localization of Pom1 at the cell middle 
also disrupts Cdr2 localization.10 One important question is how 
these 2 Cdr2-dependent functions of Pom1 in temporal and spa-
tial regulation of division are coordinated.
Here, we make 3 main discoveries: we quantitatively describe 
the profiles of Pom1 and Cdr2 at the cell cortex, which reveal 
much lower length-dependent overlap than previously appreci-
ated; we demonstrate that distinct Pom1 levels define the loca-
tion of Cdr2 node assembly and the timing of their activation; 
finally, we show that Pom1 inhibits Cdr2 function independently 
of regulating its localization. Thus, distinct levels in Pom1 gra-
dients serve to localize and inhibit the same substrate to position 
division and delay mitosis.
Results
Description of Pom1 and Cdr2 cortical distributions over 
the cell cycle
The regulation of Cdr2 by Pom1 likely takes place at the 
plasma membrane, where both proteins localize. To describe the 
distributions of Pom1 and Cdr2 at the plasma membrane over 
the cell cycle and probe how these proteins may sense cell size, 
we developed a semi-automated image analysis plug-in (called 
Cellophane), allowing measurement, sorting, and averaging of 
cortical profiles for cells of defined cell length (Fig. 1A and B; 
Fig. S1A–D, see extended “Experimental Procedures”). These 
exclude most, but maybe not all, cytoplasmic contributions of 
Pom1 (see “Discussion” for a possible function of Pom1 in the cyto-
plasm). The shape of the Pom1 gradient from cell ends remained 
identical in cells of increasing sizes, with a medial region of basal 
(but non-zero) amounts of Pom1 that widened linearly with cell 
length (~3-fold from cell birth to mitotic entry; Fig. 1B–D). The 
constant shape of Pom1 gradients in cells of distinct lengths is 
in agreement with the idea that it may serve as a measure of cell 
length. Remarkably, however, the amount of Pom1 at the very 
cell middle was identical in cells of distinct cell lengths (Fig. 1E).
Cdr2 domain width and intensity also increased ~1.5-fold 
over the cell cycle (Fig. 1B, D, and F). Manual analysis of Pom1 
and Cdr2 node distributions in wild type or cdc25-22 mutant, 
which divides at a longer cell size, confirmed these results (as pre-
viously also noted in ref. 13) and further showed a linear increase 
in node numbers with cell length (as reported recently in ref. 28) 
(Fig. 1G; Fig. S1E and F). Thus, Cdr2 domain grows in length, 
node number, and intensity as cells grow longer within an enlarg-
ing region of basal Pom1.
We note that the Pom1 basal domain enlarged faster than the 
Cdr2 domain (Fig. 1D; Fig. S1F). Consistently, the degree of 
overlap between the Pom1 and Cdr2 curves, as measured by the 
fluorescence value at the intersection of the curves, diminished 
slowly with cell length (Fig. 1H). Thus, both Pom1 and Cdr2 
profiles contain information about the length of the cell, and the 
overlap between the 2 curves is small.
These results contrast with previously published Pom1 dis-
tributions derived from sum projections of total cellular fluo-
rescence, including cytoplasm,9,10 which described significantly 
higher Pom1 levels, and thus overlap with Cdr2, at the middle 
of short cells. They raise the question of how Pom1 negatively 
regulates Cdr2 for mitotic commitment. Two main hypotheses 
can be formulated: (1) Pom1 may prevent Cdr2 node assembly 
at cell poles, as for its role in division placement. The widening 
of the basal-level Pom1 zone would allow for an increase in Cdr2 
amounts at the medial cortex, eventually reaching a threshold 
for mitotic commitment. This model does not require overlap 
between Pom1 and Cdr2—indeed, it presumes that their local-
izations be non-overlapping; (2) Pom1 may inhibit Cdr2 activ-
ity. We use here the term “Cdr2 activity” not to strictly describe 
kinase activity, but to convey more widely “Cdr2 functionality”, 
independent of localization. We do not address here directly 
whether Pom1 serves as length sensor: this inhibition may take 
place constitutively at the cell middle within the basal Pom1 
domain, or in a cell length-dependent manner within the cell 
length-dependent overlap zones between Pom1 and Cdr2 or even 
along the entire plasma membrane (see “Discussion”). A combi-
nation of both models can also be envisaged. Below, we test some 
predictions made by these models.
A separation-of-function allele of pom1 reduces cell size at 
division without affecting Cdr2 localization
Pom1 is known to regulate Cdr2 localization.9,10 Thus, a first 
simple hypothesis, as stated above, is that Pom1 controls mitotic 
timing through regulating Cdr2 localization.
However, while dissecting the mechanisms of Pom1 gradient 
formation,18 we fortuitously identified a novel pom1 separation-
of-function allele, pom1Δ305N, by integrating at the pom1 locus 
under endogenous promoter our longest N-terminal truncation 
(deletion of aa 10-303) still competent for localization. pom1Δ305N 
cells displayed no defects in septum position and minor defects 
in switch to bipolar growth. By contrast, these cells divided at a 
shorter cell size than wild-type cells (Fig. 2A). Thus, the func-
tions of Pom1 in temporal and spatial regulation of cell division 
can be genetically separated.
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Figure 1. Distribution of pom1 and Cdr2 in wild-type cells. (A) Average projection of 5 middle sections taken at 2-s intervals of pom1-tdtomato and 
Cdr2-meGFp, and segmented cell cortex as obtained from the Cellophane plugin. Landmarks for cell tips and center are used to subsequently align the 
fluorescent profiles. (B) Distribution of pom1 and Cdr2 at the cortex of wt cells of increasing length, obtained with the Cellophane plugin. By conven-
tion the high peak of pom1 is represented on the left. (C) pom1-tdtomato distribution on the cell cortex in cells of different cell sizes aligned to the tip. 
(D) Length of the Cdr2-meGFp domain above a threshold of 150 (a.u.) and of the pom1-tdtomato basal domain below a threshold of 150 (a.u.) relative to 
cell length in a wt background. (E) total cortical pom1 level over 2 µm at the cell middle relative to cell length. (F) Integrated intensity of the Cdr2-meGFp 
signal over a threshold of 150 (a.u.) relative to cell length in wild-type cells. (G) Manual measurement of the length of the domain occupied by Cdr2 nodes 
relative to cell length in wt and cdc25-22 cells. (H) Fluorescence level (a.u) at the points where pom1-tdtomato and Cdr2-meGFp profiles intersect. All 
P values are obtained from 2-sided linear regression tests.
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We investigated the distribution of 
Cdr2 in pom1Δ305N mutant cells: Cdr2 
domain width and intensity at the 
cell middle showed no, or only minor, 
changes compared to wild-type cells of 
identical length (Fig. 2B), consistent 
with the normal septum position. Cdr2 
node localization is controlled not only 
by Pom1, but also by an as-yet-unde-
fined, growth-dependent pathway, with 
Cdr2 spreading all around only the non-
growing cell end of pom1Δ cells.9,10 To test 
whether Cdr2 remained restricted to the 
cell middle in pom1Δ305N cells due to their 
still largely bipolar growth, we investi-
gated the effect of pom1Δ305N in otherwise 
monopolar bud6Δ cells,29 in which Pom1 
localizes normally (see Fig. S3A). Here 
again, Cdr2 distribution and septum 
position were unaffected by pom1Δ305N 
(Fig. S2A and B; septum placement at 
0.472 ± 0.018 of cell length in bud6Δ 
vs. 0.475 ± 0.020 in bud6Δ pom1Δ305N), 
indicating that, even in cells growing in 
a monopolar manner, pom1Δ305N does not 
affect Cdr2 localization. Thus, Pom1-
dependent regulation of mitotic com-
mitment appears largely independent of 
Cdr2 localization.
Distinct levels of Pom1 activity regu-
late division timing and positioning
What is the underlying defect of 
pom1Δ305N? Pom1Δ305N-GFP localized at 
cell tips, formed gradients similar to wild-
type Pom1, but was present at about 60% 
of wild-type levels as assessed by both 
western blotting and GFP fluorescence 
quantification (Fig. 2C–E). However, 
both overexpression of pom1Δ305N under 
nmt41 promoter and mis-targeting of 
Pom1Δ305N to the cell middle by fusion 
with Cdr2 C terminus produced an 
increase in cell length at division, similar 
to that observed with full-length Pom1 
(Fig. 2F; Fig. S2C and D),9 indicating 
that this allele is still able to delay mitotic 
entry. Consistently, Pom1Δ305N remained 
fully active in vitro (Fig. S2E). Though 
we cannot exclude that this allele may 
also be deficient in specific molecular 
interactions, the lower expression levels 
of Pom1Δ305N and its preserved ability to 
delay mitotic entry upon overexpression 
suggest that distinct levels of Pom1 or 
Pom1 activity may regulate division tim-
ing and positioning.
Figure 2. A separation-of-function allele of pom1 reduces cell size without affecting Cdr2 localiza-
tion. (A) Mean cell length at division (left), mean septum position (middle), and mean % bipolar 
septated cells (right) in wt, pom1Δ305N and pom1Δ cells (n > 190 for each measure from 3 independent 
experiments). error bars: SD. (B) Localization of Cdr2-GFp in wt and pom1Δ305N background, and dis-
tribution profiles in 8.5–10.5-µm cells as obtained using Cellophane plugin (right). Data from one 
of 3 experiments is shown. Cell tips are outlined. Spinning disk medial plane images. Bar: 5 µm. 
(C) Localization of GFp-tagged pom1 and pom1Δ305N mutant, and distribution profiles in 8.5–10.5-
µm cells as obtained using Cellophane plugin (right). Data from one of 3 experiments is shown. 
Spinning-disk maximum projections. Bar: 5 µm. (D) Western blot of total protein levels of GFp-
tagged pom1 in same strains as in (C) Alpha-tubulin serves as the loading control. (E) Quantification 
of the intensity of GFp signals as seen in western blots (corrected to the tubulin signal) and in cells 
(corrected to background signal and signal from an untagged strain, n = 36 cells), on strains as in (C). 
Values of pom1-GFp set to 1. error bars: SD. (F) Mean cell length at division and normalized mean 
intensity during interphase of pom1-GFp and pom1Δ305N-GFp expressed from pom1 promoter or over-
expressed from pnmt41 or nmt1 promoter. Cells were grown in eMM+3S for 24 h with or without 
thiamine. one of 3 experiments is shown. error bars: SD.
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We tested this hypothesis more directly. First, we used an ana-
log-sensitive allele, Pom1as1, which can be inhibited by small-mol-
ecule inhibitors of the PP1 family. We had previously shown that 
10–20 µM 1NM-PP1 blocks Pom1as1.9,27 3MB-PP1 was about 
10-fold more efficient, with 1 µM fully inhibiting Pom1as1 or 
Pom1as1-tdTomato, producing pom1KD-like phenotypes, but hav-
ing no undesired off-target effects on wild-type cells (Fig. 3A–C). 
Like pom1KD or pom1Δ, these cells showed Pom1 delocalization, 
NETO failure, Cdr2 domain extension over the non-growing 
cell half, and division off-center at short cell size (Fig. 3A–C).
Remarkably, 10–20-fold lower 3 MB-PP1 dosage 
(0.05– 0.1 µM) separated Pom1 functions, resulting in bipo-
lar cells dividing medially at short cell size, with Cdr2 medial 
localization and amounts similar to wild-type (Fig. 3B and C; 
Table S3). At these low doses, Pom1 was clearly partially inhib-
ited, as it moderately delocalized along the lateral cell cortex 
(Fig. 3A and B; refs. 18 and 30). Intermediate 3MB-PP1 dos-
ages (0.25–0.5 µM) had similarly short cells, with progressively 
more severe Cdr2 delocalization and division site misposition-
ing defects (Fig. 3A and C). The distribution of Cdr2 was not 
dependent on the growth pattern of the cells, as it remained 
unchanged in uniformly monopolar bud6Δ cells compared to 
bud6+ cells (Fig. S3B). Thus, partial reduction of Pom1 activity 
by pharmacological inhibition affects cell division timing but not 
Cdr2 localization or cell division positioning.
Pom1 is haploinsufficient for control of mitotic commitment
To test the importance of Pom1 protein dosage, we used dip-
loid cells, in which, like in haploids, pom1 deletion led to shorter 
cell size at division and mispositioned septa (Fig. 4A and B). 
Remarkably, heterozygous pom1Δ/pom1+ diploid cells were sig-
nificantly shorter than wild-type cells, but divided medially 
(Fig. 4A and B; Table S4). Thus, pom1 is haploinsufficient 
for its role in division timing, but not positioning, indicating 
that here again the 2 functions require distinct levels of Pom1 
protein.
We investigated the distribution of Pom1 and Cdr2 in dip-
loid wild-type pom1-tdTomato/pom1-tdTomato and heterozygous 
pom1Δ/pom1-tdTomato cells. In both cases, one copy of Cdr2 was 
tagged with GFP. As in haploids, Pom1 formed polar gradients 
and small clusters (Fig. 4C).18,19 In the wild-type cells, Pom1 
Figure 3. partial inhibition of pom1 activity separates its functions in mitotic commitment and Cdr2 localization. (A) Localization of pom1as1-tdtomato 
(red) and Cdr2-meGFp (green) with increasing doses of 3MB-pp1. top panels show medial section confocal images of pom1as1-tdtomato; bottom pan-
els show maximum projections of the merged channel. Bar: 5 µm. (B) Distribution of pom1as1-tdtomato and Cdr2-meGFp in 7.5–9.5 µm cells as in (A), 
obtained with the Cellophane plugin. (C) Mean cell length at division (left), mean septum position (middle) and mean % bipolar septated cells (right) in 
wt and pom1as1 from 3 independent experiments. error bars: SD.
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gradients from cell ends remained of constant shape in cells of 
distinct lengths, reaching a uniform basal level at the cell middle 
(Fig. 4D), though Cdr2 domain width and levels did not increase 
with cell length. As in haploid cells, there was an overlap between 
Pom1 and Cdr2 profiles. However, this overlap was almost con-
stant and diminished only very moderately with cell length 
(Fig. 4G). In heterozygous pom1Δ/pom1+ diploid cells, Pom1 
levels were significantly reduced throughout the cortical profile, 
including within the medial basal domain (Fig. 4E and F). Cdr2 
was localized normally at the cell middle, and again its levels did 
not increase with cell length (Fig. 4E). A largely constant overlap 
was also present at the intersection of both profiles but, probably 
owing to the lower Pom1 medial levels, was lower than in the 
wild-type situation (Fig. 4G).
Figure 4. pom1 is haploinsufficient for mitotic timing. (A) Calcofluor staining of pom1-GFP/pom1-GFP, pom1Δ/pom1-GFP, and pom1Δ/pom1Δ diploid cells. 
(B) Mean cell length at division (top), mean septum position (botton) in strains as in (A). error bars: SD. (C) Localization of pom1-tdtomato (grey and 
red) and Cdr2-meGFp (green) in wt and heterozygote pom1Δ/pom1+ diploid cells. In both strains, a single cdr2 allele was tagged and all pom1+ alleles 
were tagged. Red arrowheads highlight a few pom1 clusters. (D) Distribution of pom1 and Cdr2 at the cortex of wt diploid cells (as in C) of increasing 
length, obtained with the Cellophane plugin. By convention the high peak of pom1 is represented on the left. (E) Distribution of pom1 and Cdr2 at the 
cortex of heterozygote pom1Δ/pom1+ diploid cells (as in C) of increasing length, obtained with the Cellophane plugin. By convention the high peak 
of pom1 is represented on the left. (F) Comparison of the pom1 profiles in 14–16-µm-long wild-type and pom1Δ/pom1+ diploid cells, as in (D and E). 
(G) Fluorescence level (a.u) at the points where pom1-tdtomato and Cdr2-meGFp profiles intersect in both wt and pom1Δ/pom1+ diploid cells. Note that 
P values were obtained from 1-sided linear regression tests.
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In summary, 3 independent lines of evidence demonstrate 
that partial reduction in Pom1 protein levels or Pom1 activity 
separates its functions in timing and positioning of cell division: 
division timing requires higher global Pom1 (activity) levels and 
is more sensitive to an alteration of these levels.
Pom1 negatively regulates Cdr2 activity
The largely unchanged distributions of Cdr2 in these pom1 
separation-of-function conditions presented above make the 
model that Pom1 simply controls mitotic entry by modulat-
ing Cdr2 increase at the cell middle unlikely. In addition, we 
Figure 5. For figure legend, see page 545.
www.landesbioscience.com Cell Cycle 545
note that the Cdr2 domain also increased in width 
and levels during cell growth in pom1Δ cells. This 
suggests that the dimensions of this domain at the 
cell cortex are set largely independently of Pom1 
during cell elongation (Fig. 5A–C). Consistently, 
simple statistical analysis of Pom1 and Cdr2 profiles 
in wild-type haploid cells (see Fig. 1) showed that 
Pom1 and Cdr2 profiles contain non-redundant 
information about cell length. Indeed both the basal 
Pom1 domain size and the Cdr2 domain area are 
significantly associated with cell size, even when 
removing the effect of the other variable (P < 2E-46 
and P < 3E-8). Including the Cdr2 domain area in a 
linear model of cell size as a function of Pom1 basal 
domain brings the explained variance from 58% 
to 63%, suggesting that the Cdr2 profile contains 
information that is not present in the Pom1 profile. 
Thus, these data are consistent with the notion that 
Cdr2 medial levels and Pom1-mediated regulation 
may contribute distinct information for mitotic 
commitment.
We tested the effect of Cdr2 levels in 2 ways. 
We first constructed heterozygous cdr2-GFP/cdr2Δ 
diploids and compared them to cdr2-GFP/cdr2+ 
cells. In these diploids, total Cdr2 levels were halved 
Figure 6. pom1 negatively regulates Cdr2 through Cdr2 
C-terminal tail. (A) Scheme of Cdr2, showing the kinase 
domain, a basic (+++) and KA-1 domain mediating 
membrane binding and the C-terminal tail, which was 
either truncated or mutated at indicated positions (red). 
(B)  Mean cell length at division in wt and indicated cdr2 
mutants. error bars: SD. (C) In vitro kinase assay of GSt-
pom1 on GSt-Cdr2750-775 with indicated mutation or on GSt 
alone. the fourth lane is an assay of GSt-pom1KD on GSt-
Cdr2750-775. top panel shows phosphorimager detection of 
32p incorporation; bottom panel shows silver-stained gel. 
(D) Localization and distribution profiles of Cdr2-meGFp 
and Cdr2S755A-S758A-meGFp in 7.5–9.5-µm cells using auto-
mated Cellophane plugin. Data from one of 2 experiments 
is shown. Cell tips are outlined. Bar: 5 µm. (E) Deletion or 
truncation of pom1 have no or little effect in cdr2S755A and 
cdr2S755A-S758A mutant cells. Mean cell length of indicated 
genotypes. error bars: SD. (F) Localization of meGFp-
tagged Cdr2 and Cdr2S755A-S758A in pom1Δ cells.
Figure 5 (See previous page). Cdr2 cortical levels increase with cell length independently of pom1 and are inhibited by pom1. (A) Cdr2-meGFp cortical 
distribution in pom1Δ in cells of 6.5–8.5 µm (blue) compared to cells of 9.5–11.5 µm (red). Standard deviation is indicated by a thin line. profiles were 
aligned to the non-growing cell pole, where Cdr2 accumulates. Dashed vertical lines indicate the cell middles. (B) Integrated intensity of the Cdr2-
meGFp signal (a.u.) relative to cell length in pom1Δ. (C) Length of the meCdr2-GFp domain above a threshold of 150 (a.u.) relative to cell length in pom1Δ 
and wild-type cells. All P values are obtained from 2-sided linear regression tests. (D) Quantification of the intensity of Cdr2-GFp signals in diploid cells 
of genotypes cdr2-GFP/cdr2+ (n = 40) and cdr2-GFP/cdr2Δ (n = 37). to account for all Cdr2 copies, the measured values for the wild-type were doubled, 
because only 1 copy of Cdr2 is tagged in this strain. Values of the wild-type set to 1. error bars: SD. (E) Mean cell length at division in strains as in (D). error 
bars: SD. (F) Images and quantification of Cdr2-meGFp expressed from its own endogenous promoter, from the nmt81 promoter and from the nmt41 
promoter. All images were taken with identical settings. the normalized mean cortical intensity of Cdr2-meGFp during interphase in the strains used in 
(G) is shown at the bottom. N =  90 cells grouped from 7 independent experiments for wt cells; n = 40 cells grouped from 2 independent experiments 
for pom1Δ cells. error bars: SD. (G) Mean cell length at division in wt or pom1Δ cells expressing Cdr2-meGFp from cdr2 promoter or overexpressing it from 
nmt81 or nmt41 promoters (n > 400 cells grouped from 7 independent experiments for wt cells; n > 240 cells grouped from 2 independent experiments 
for pom1Δ cells). error Bars: SD. (H) Mean cell length at division in wild-type or pom1Δ cells with untagged cdr2+ expressed from cdr2 promoter or over-
expressed from nmt81 promoter (n > 600 from 6–8 independent experiments each). Cells were grown for 36 h at 30 °C in eMM + 3S without thiamine. 
error Bars: SD.
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(Fig. 5D). However, the length of these cells was the same as that 
of wild-type diploids (21.1 ± 2.2 μm vs. 21.5 ± 2.2 μm, respec-
tively; Fig. 5E; Table S4), suggesting that Cdr2 is not limiting 
for mitotic commitment.
Second, we overexpressed mEGFP-tagged Cdr2 in haploid cells 
by placing cdr2 ORF under the control of nmt81 or nmt41 pro-
moters at the cdr2 endogenous locus (Fig. 5F and G; Table S5). 
Previous data had shown that strong Cdr2-GFP overexpression 
caused dominant-negative effects, lengthening cells at division.13 
Similarly, expression from the nmt41 promoter, which induced a 
7-fold fluorescence increase in Cdr2-mEGFP cortical levels com-
pared to expression from cdr2 promoter, led to an increased cell 
length at division. By contrast, Cdr2-mEGFP expression from 
nmt81 promoter, which induced a 2.8-fold increase in cortical lev-
els, did not show a dominant-negative effect, but also did not show 
significant reduction in cell length at division. We confirmed these 
results by overexpression of non-tagged Cdr2. In this case, expres-
sion from the nmt81 promoter caused a small, though significant, 
reduction in cell length at division in wild-type cells, suggesting 
that moderate increase in Cdr2 levels can weakly promote mitotic 
commitment (Fig. 5H). Remarkably, however, this same level of 
Cdr2-mEGFP or untagged Cdr2 expression led to an important 
reduction in cell length at division in pom1Δ cells (Fig. 5G and 
H; Table S5). Thus, mild Cdr2 overexpression accelerates mitotic 
entry much more potently in absence of Pom1.
Together, these results indicate that a cell length-dependent 
increase in Cdr2 levels may contribute to cell size measure, but 
only efficiently upon removal of Pom1-mediated inhibition. Thus, 
Pom1, in addition to controlling Cdr2 localization to the cell mid-
dle, also keeps it in an inactive form.
The C-terminal tail of Cdr2 is required for Pom1-mediated 
inhibition
Some members of the AMPK superfamily, which includes 
the SAD-like kinases, to which Cdr2 belongs, are subject to 
auto-inhibition by their C terminus.31 To test if Cdr2 was sub-
ject to auto-inhibition, we produced a mutant carrying a trunca-
tion of the very C-terminal tail (cdr2Δ751-775) beyond the KA-1 
domain-mediating membrane binding (Fig. 6A; Rincon et al., in 
preparation). This truncation did not affect Cdr2 localization,13 
but promoted cell division at a shorter size than wild-type cells 
(Fig. 6B; Table S6), suggesting that Cdr2 C-terminal tail nega-
tively regulates Cdr2 activity.
Cdr2 C-terminal tail was phosphorylated by Pom1 in vitro 
(Fig. 6C). Alanine substitution of S755 but not S758, both within 
DYRK consensus motifs, blocked phosphorylation, showing 
that Cdr2 is phosphorylated by Pom1 on S755 in vitro. In vivo, 
Cdr2S755A-S758A-GFP localized medially with similar amounts to 
wild-type, and these cells divided medially (Fig. 6D and data not 
shown). By contrast, this double mutant, as well as cdr2S755A sin-
gle mutant, divided at a shorter size than wild-type cells (Fig. 6B; 
Table S6). These similar phenotypes to the C-terminal tail trun-
cation are consistent with the notion that Pom1 phosphorylates 
this region. We note that the cdr2S758A single mutant was also 
shorter in vivo, suggesting the Cdr2 C-terminal tail is easily 
unfolded or may be the target of several kinases. Remarkably, 
pom1 deletion or N-terminal truncation (pom1Δ305N) had very 
little effect on cell length in cdr2S755A-S758A or cdr2S755A mutant 
alleles (Fig. 6E; Table S6), indicating that these alleles are largely 
insensitive (epistatic) to Pom1. However, in pom1Δ cells, these 
double mutants showed mis-positioned septa, like pom1Δ single 
mutant. In addition, Cdr2S755A-S758A-GFP, like wild-type Cdr2-
GFP, was aberrantly localized around the non-growing cell end 
(Fig. 6F), indicating that this allele remains sensitive to Pom1-
dependent localization signal.
In summary, these data are consistent with the idea that Cdr2 
C-terminal tail serves to inhibit Cdr2 activity upon phosphory-
lation by Pom1. Removal of this inhibitory mechanism renders 
Cdr2 largely insensitive to Pom1-dependent regulation of its 
functionality for mitotic commitment, but does not affect its 
localization for division site placement. Thus, 2 distinct Pom1 
signals independently regulate Cdr2 activity and localization.
Discussion
Where and when cells divide are important biological ques-
tions. In fission yeast, Pom1 kinase is involved in both temporal 
Figure 7. possible models of differential pom1-dependent regulation of 
Cdr2 and cell length sensing. (A) pom1 may inhibit Cdr2 in regions of 
high pom1 concentration near cell poles, concomitant with Cdr2 detach-
ment from the plasma membrane, leading to accumulation of inhibited 
Cdr2 at the cell middle. Cell length may be perceived through the ratio of 
pom1-covered to total cell cortex. (B) pom1 may inhibit Cdr2 primarily in 
the zones of overlap between Cdr2 and pom1 profiles. Reduction of the 
extent of overlap with cell length may provide a measure of cell length. 
(C) pom1 may inhibit Cdr2 throughout the medial domain, and not serve 
as cell length sensor, though even in this case the cell length-dependent 
overlap on the edges of the medial domain may modulate this inhibi-
tion. In each model, the horizontal lines indicate possible concentration 
levels at which pom1 exerts its inhibitory and displacing activities on 
Cdr2. See text for details.
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and spatial regulation of cell division. We and others have previ-
ously shown that Pom1 is an inhibitor of mitotic commitment, 
which negatively regulates Cdr2, itself part of a Wee1 inhibitory 
pathway.9,10 These studies proposed that the polar Pom1 gradients 
form a size-perception system to couple cell length with mitotic 
entry, though recent data challenged the view that Pom1 acts as 
cell length sensor.20 Pom1 also ensures medial placement of the 
division plane by restricting Cdr2 and Mid1/anillin node local-
ization to the medial cortex.21,26,27 In this study, we provide 3 new 
lines of evidence that illuminate the interaction between Pom1 
and Cdr2. First, we provide a quantitative description of Pom1 
and Cdr2 distribution at the cell cortex, which puts in question 
simple models of cell-length sensing. Second, we show that Pom1 
controls mitotic commitment through Cdr2 in ways distinct 
from the regulation of Cdr2 localization. Finally, we demonstrate 
that Pom1’s function in the timing and positioning of division 
are genetically separable and mediated by distinct Pom1 levels. 
Thus, 2 distinct Pom1 levels exert distinct effects on the same 
substrate for timing and positioning of division.
Two distinct Pom1 signals regulate timing and positioning 
of division
For division positioning, it has been clearly demonstrated that 
Pom1 modulates Cdr2 localization.9,10 Cdr2, in turn, contributes 
to positioning cell division medially, by localizing Mid1/anillin 
to the cell middle.21,26,27 How Pom1 regulates Cdr2 for mitotic 
commitment has remained an important question. We show here 
that Pom1 modulates mitotic commitment in ways distinct from 
its regulation of Cdr2 localization.
Indeed, 4 distinct modifications of Pom1 or Cdr2 function: 
(1) truncation of the first 300 residues of Pom1 in the pom1Δ305N 
allele; (2) partial pharmacological inhibition of Pom1as1; (3) pom1 
haploinsufficiency in diploid cells; and (4) cdr2 C-terminal tail 
mutation or truncation, advance the cell cycle without altering 
Cdr2 distribution patterns at the cell middle. In each case, the 
cells divide prematurely at a short cell size but localize Cdr2 cor-
rectly and divide medially even in cells growing only from one 
cell pole. Thus Pom1-dependent regulation of mitotic commit-
ment occurs independently of a change in Cdr2 distribution.
Roles of Cdr2 levels and distribution for mitotic timing
Our profile measurements show that, in haploid cells, Cdr2 
medial levels and domain width increase with cell length, rais-
ing the possibility that Cdr2 medial levels may be important for 
mitotic commitment. This increase over the cell cycle is largely 
pom1-independent, as it is also observed in pom1Δ mutant. In 
diploid cells, Cdr2 did not significantly increase with cell length. 
One possibility is that Cdr2 medial levels are defined primarily 
through a “growth”-dependent pathway that excludes Cdr2 from 
sites of growth near cell tips. In diploid cells, growth zones may 
be distant enough from the cell middle, and thus not interfere 
with Cdr2 levels in cells of any size. In any case, halving Cdr2 
levels in diploids had no influence on the timing of mitotic entry. 
In addition, low-level overexpression of Cdr2 advanced the cell 
cycle only weakly in wild-type cells, suggesting that, by them-
selves, Cdr2 levels are a poor indicator of mitotic entry.
Furthermore, it is remarkable that the Cdr2 tail mutants 
divide at almost the same length in pom1+ cells, in which Cdr2 
is medially localized, and in pom1Δ cells, where Cdr2 covers over 
half of the cell surface. Therefore, the precise spatial distribu-
tion of Cdr2 at the cortex is by itself not a major determinant of 
cell length control, though it may underlie the remaining length 
difference observed. In conjunction with Pom1-dependent reg-
ulation, Cdr2 localization and amounts may dictate where it 
encounters regulation by Pom1 and, thus, contribute to the tim-
ing of mitotic entry.
In summary, these data are inconsistent with the idea that 
Pom1 simply controls Cdr2 medial accumulation for mitotic 
commitment, even if this was implemented in 2 theoretical 
papers of cell cycle control.32,33 Instead, they suggest that Cdr2 
levels may play a minor role in mitotic commitment timing, but 
additively or synergistically to relief of Pom1 inhibition.
Pom1 inhibits Cdr2 through its C-terminal tail
If Pom1 does not control mitotic commitment by simply 
modulating Cdr2 distribution at the cortex, what is the mecha-
nism? We suggest that Pom1 directly inhibits Cdr2 activity or 
functionality within the medial nodes. This idea is in agreement 
with the fact that an artificial increase of Cdr2 cortical pool 
advances mitosis potently only when cells are deleted for pom1, 
suggesting Cdr2 is kept in check by Pom1. We have deciphered a 
first molecular mechanism for this inhibition. This relies on the 
phosphorylation by Pom1 of Cdr2 C-terminal tail that may ful-
fill an auto-inhibitory function when phosphorylated. cdr2 tail 
mutants are epistatic to pom1, indicating that this represents a 
major mechanism by which Cdr2 is inhibited by Pom1. Thus, 
Pom1 inhibits Cdr2 through its C-terminal tail.
Auto-inhibition is classically achieved by intramolecular inter-
actions, as has been documented for some members of the AMPK 
superfamily of kinase to which Cdr2 belongs, such as MELK1.31 
However, we have not found evidence for intramolecular inter-
actions in Cdr2 (our unpublished results). Further analysis will 
be necessary to determine whether the Cdr2 tail inhibits Cdr2 
kinase activity directly or via other means, such as modulation 
of interactions with partners involved in cell size control. As the 
cdr2 tail mutants divide at a longer cell size than pom1Δ cells, 
Pom1 may also negatively regulate mitotic entry through addi-
tional mechanisms, which remain to be characterized. Pom1 
may, for instance, phosphorylate other components of the Cdr2 
nodes, modulating their accessibility to Cdr2. However, as 
double mutants between cdr2 tail mutants and pom1Δ are also 
longer than pom1Δ, an alternative explanation is that this Cdr2 
C-terminal tail also plays a positive role in Cdr2 activation, which 
is blocked by these mutations.
The importance of Pom1 levels
All 3 instances of separation of Pom1 functions, where Pom1 
is functional to position division medially, but not to delay 
mitotic entry, correspond to a reduction in Pom1 protein or 
activity levels. First, in the case of pom1Δ305N, the major identified 
difference is that this allele is found at about 60% of wt Pom1 
levels. However, we cannot exclude that this Pom1 truncation 
does not cause other adverse effects on Pom1 function. Second, 
an inhibitor dosage about 20-fold lower than that required for 
complete inhibition of Pom1 was sufficient to block mitotic con-
trol in pom1as1 cells, suggesting that the control of mitotic entry 
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is exquisitely sensitive to Pom1 activity levels. We note that in 
this case Pom1 localization is modified, because Pom1 activity is 
required for Pom1 detachment from the plasma membrane.18 The 
increased amount of Pom1as1 at mid-cell upon partial inhibition 
likely represents inactive Pom1. Finally, the clearest demonstra-
tion lies in the diploid experiment, where halving Pom1 levels is 
enough to accelerate the cell cycle, but does not impede medial 
division. We conclude that control of mitotic entry requires 
higher global levels of Pom1 activity than control of division 
positioning.
There is increasing evidence that several kinases act not as on-
or-off switches, but rather exert distinct actions at distinct dos-
ages. For instance, different levels of activity of cyclin-dependent 
kinase elicit entry into S phase and into mitosis.34 Similarly, dis-
tinct levels of Polo-like kinase are required for mitosis and cytoki-
nesis,35 and different levels of Aurora kinase underlie its functions 
in chromosome compaction and in regulation of kinetochore–
microtubule interaction.36 It is also interesting to note that the 
Pom1-related kinase DYRK1A, which lies within the critical 
region of human chromosome 21 involved in trisomy, is highly 
dosage-sensitive, exhibiting both haploinsufficiency and dupli-
cation phenotypes in brain growth, though its mode of action 
appears distinct from that of Pom1.37,38
In addition to Pom1-dependent signals, the Cdr2 regulatory 
network also integrates other inputs. The cell length-dependent 
increase of Cdr2 cortical levels may contribute in conjunction 
with Pom1-dependent regulation. Additional regulations are 
operated at the level of Cdr1 by Nif1, which localizes to cell 
poles,9,39 and by Skb1, which localizes to distinct cortical nodes.28 
Finally, a recent study revealed that this network is subject to 
upstream regulations by the Nek/NIMA-family kinase Fin1, 
which localizes to the spindle pole body.40 Future work should 
determine the relative contribution of each of these inputs for 
mitotic timing.
Where does Pom1 inhibit Cdr2?
Pom1 and Cdr2 both localize at the plasma membrane, sug-
gesting this is where regulation of Cdr2 by Pom1 takes place. In 
support of this hypothesis, Cdr2 requires membrane binding to 
be functional,13 and forced localization of Pom1 at the medial 
cortex strongly delays mitotic commitment.9,10 However, the 
cytosolic pool of Pom1 may also regulate Cdr2. Indeed, previous 
data showed that cytosolic Pom1 in tea4Δ cells, in which Pom1 is 
not dephosphorylated and fails to bind the plasma membrane,18 
is still competent to delay the cell cycle, though less potently 
than membrane-targeted Pom1.9 This cytosolic pool is very low 
in wild-type cells, and it is unclear how much it may contribute 
to Cdr2 regulation. In this work, we focused on the membrane-
localized pools of Pom1 and Cdr2.
Our quantifications of Pom1 and Cdr2 profiles at the cell 
periphery depart from previously published quantifications, 
which included the entire cell volume including cytoplasm. In 
these earlier quantifications, Pom1 levels at the cell middle dimin-
ished with increasing cell length.9,10 These previously observed 
cell length-dependent changes in medial Pom1 levels may be due 
to cytoplasmic modulations or to cell size-dependent changes in 
the volume of the nucleus, from which Pom1 is excluded.41 We 
now show that Pom1 levels are identical at the medial cortex of 
short and long cells, though the amounts of Pom1 on the edges of 
the Cdr2 domain are higher in smaller cells. As discussed above, 
for mitotic timing Pom1 inhibits Cdr2 in addition to regulating 
its localization. This thus begs the question of where this inhibi-
tion takes place, and whether this occurs in a cell length-depen-
dent manner.
We can consider 3 possible locations of the Pom1-mediated 
Cdr2 inhibition (Fig. 7). In each case, we hypothesize that Cdr2 
transiently binds the cortex at random locations, but high con-
centration of Pom1 near cell poles induces faster detachment, 
leading to Cdr2 accumulation at mid-cell (Rincon et al., in 
preparation).
The first model (Fig. 7A) is that Pom1 inhibits Cdr2 activity 
wherever it encounters it around the entire cell cortex, indepen-
dent of the modulation of cortical dynamics. The observed dif-
ferential sensitivities to Pom1 levels suggest that Cdr2 inhibitory 
phosphorylation sites are poorer substrates than sites modulat-
ing localization. Inhibition would thus occur mostly close to cell 
poles where Pom1 concentration is highest. This model does not 
require an extensive overlap between Pom1 and Cdr2, but would 
require a slow turnover of Pom1-dependent inhibitory phosphor-
ylation compared to the modifications regulating Cdr2 dynam-
ics on the cortex to allow accumulation of inhibited Cdr2 at the 
cell middle. This model may accommodate Pom1 as cell length 
sensor: as cells elongate, the ratio of Pom1-covered to total cortex 
diminishes, which may reduce the likelihood of Cdr2 inhibition 
by Pom1. Thus, cell length may be perceived through the ratio of 
polar to total cortex.
The second model (Fig. 7B) is conceptually similar to the 
original model, with Pom1 inhibiting Cdr2 activity on the edges 
of its domain, where Cdr2 exposure to Pom1 diminishes as cells 
elongate. This could trigger mitotic entry in a cell size-depen-
dent manner as originally proposed.9,10 In this model, the sites 
modulating Cdr2 activity would be better Pom1 substrates than 
those modulating Cdr2 dynamics on the cortex. Yet, the low 
concentration of Pom1 in the regions where it inhibits Cdr2 (at 
the edges of the Cdr2 domain) would render Cdr2 function in 
mitotic commitment more sensitive to global modifications of 
Pom1 activity than Cdr2 localization. The overall small variation 
in Cdr2 exposure to Pom1 as cells elongate suggests this measure-
ment would be noisy. In addition, the Pom1 and Cdr2 overlap in 
diploid cells is very poorly correlated to cell length, suggesting 
this mechanism would not permit size measurements in diploids.
The third possibility (Fig. 7C) is that, as above, Pom1 concen-
tration at mid-cell may be too low to displace Cdr2, yet sufficient 
to inhibit its functionality, but that this inhibition takes place 
throughout the Cdr2 domain and is not significantly alleviated 
as cells elongate. In this case, Pom1 gradients would not directly 
measure cell length, but serve to keep Pom1 away from mid-cell. 
The uniform medial Pom1 basal levels, in which a cytoplasmic 
signal could also contribute, would simply function as constitu-
tive buffer for mitotic commitment. Medial cortical levels may 
be modulated, not as function of cell length, but in response to 
other stimuli, for instance for cell length adaption under stress. 
Such a model would be consistent with the recent finding that 
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pom1Δ cells are still homeostatic for cell length control.20 Future 
work, for instance through development of tools allowing the dis-
tinction of active and inactive Cdr2 in situ, will be required to 
distinguish between these models.
In summary, our work demonstrates that different levels of the 
same kinase, organized in concentration gradients, both delin-
eate a functional domain and regulate its activity. One major 
challenge will be to define how this benefits cell size control.
Materials and Methods
Strain construction and culture
Standard S. pombe media and genetic manipulations were 
used.42 All strains used in the study were isogenic to wild-type 
972 and are described in Table S1. Strains from genetic crosses 
were selected by random spore germination or tetrad dissection 
and replicated in plates with appropriate supplements or drugs. 
Transformations were performed using the lithium acetate-
DMSO method as described.43 Standard molecular biology tech-
niques were used to create all plasmids described in Table S2.
All pom1 and cdr2 mutant alleles were integrated at their 
respective endogenous locus, as detailed in Table S1 and below. 
For generation of pom1Δ305N mutant, a DNA fragment linking 
pom1 5’UTR (725 bp upstream of start of pom1 ORF) with 
pom1 ORF (from 910 bp downstream of the start of the pom1 
ORF+569 bp of the 3’UTR) lacking the sequence encoding aa 
10-303 was generated by PCR stitching and transformed in a 
pom1::ura4+ strain for integration at pom1 locus in replace-
ment of ura4 sequence by homologous recombination. Note 
that the name Δ305N is not a direct description of the exact 
amino acids absent in this allele. Transformants were selected on 
5-FOA plates and confirmed by diagnostic PCRs and sequenc-
ing. Tagging of pom1Δ305N with Cdr2C-GFP was performed as 
described.9 Integration of nmt41 promoter and tagging with 
GFP were done using a PCR-based approach43 and confirmed 
by PCR.
cdr2 phosphosite mutants were produced by site-directed 
mutagenesis of pSM788, a pBluescript plasmid carrying Cdr2 
ORF, 5’UTR and 3’UTR regions between NotI and SalI. 
Plasmids were digested with NotI and SalI before transforma-
tion of YSM1164 for integration at cdr2 locus in replacement of 
ura4 sequence by homologous recombination. Transformants 
were selected on 5-FOA plates and confirmed by diagnostic 
PCRs and sequencing. Deletion strains were constructed using a 
PCR-based approach43 and confirmed by PCR. cdr2S755A-S758A was 
C-terminally tagged with mEGFP by transforming it with NotI-
BamHI-AgeI digested fragment of pSM990. Transformants were 
selected on YE-G418 plates and confirmed by diagnostic PCRs.
To produce the Pnmt41-cdr2-mEGFP and Pnmt81-cdr2-
mEGFP strains, nmt41 or nmt81 promoters were inserted at 
BamHI site in pSR34, a pFA6a-mEGFP-KanMX6 derived plas-
mid carrying cdr2 promoter and terminator for integration at 
cdr2 locus in replacement of the NatMX6 cassette by homologous 
recombination. Plasmids were digested with NotI before trans-
formation. For Pnmt81-cdr2 and Pnmt81-cdr2S755A-S758A, nmt81 
promoter was inserted at BamHI site in pSR34. Plasmids were 
digested with NotI, AfeI, and AscI, and the largest band purified 
before transformation of YSM2224 and YSM2226, respectively.
Diploid strains were created by crossing parental haploids 
bearing ade-M210 and ade-M216 alleles and selecting diploids 
on plates lacking adenine (EMM supplemented with uracil and 
leucine) at 30 degrees. Single colonies were picked on YE plates 
and imaging was done in EMM supplemented with adenine, ura-
cil, and leucine at 30 °C.
To induce Cdr2 or Cdr2-mEGFP overexpression from nmt81 
and nmt41 promoters,44 cells were first grown overnight at 30 °C 
in EMM supplemented with adenine, uracil, leucine, and thia-
mine (5 µg/ml) then washed 5 times with sterile water and incu-
bated for 24 h at 30 °C in the same medium without thiamine 
to induce expression. For Pom1-GFP and Pom1Δ305N-GFP over-
expression from nmt1 and nmt41 promoters, cells were grown for 
24 h at 30 °C in EMM supplemented with adenine, uracil, leu-
cine, with or without thiamine (5 µg/ml).
For pom1as1 mutants, cells were grown overnight at 30 °C in 
EMM supplemented with adenine, uracil, leucine, diluted in the 
same medium next morning and required dosages of 3MB-PP1 
(Toronto Research Chemicals Inc) dissolved in methanol) were 
added at O.D»0.4 for 4 h before imaging.
Calcofluor (Sigma) was added at a final concentration of 
5 μg/ml from a 200× stock solution (1 mg/ml).
Microscopy and image analysis
For all images shown and analyzed, except those of Figures 1G 
and 5F and Figures S1E and F, as well as all images for Cellophane 
analysis (see below), cells were grown in EMM with appropriate 
supplements at 30 ºC and imaged at room temperature (about 
23 ºC). Image acquisition was performed on a Perkin Elmer 
Leica DMI4000B inverted microscope equipped with an HCX 
PL APO × 100/1.46NA oil objective and a PerkinElmer Volocity 
Confocal system spinning disk microscope including a Yokagawa 
CSU22 real-time confocal scanning head, solid-state laser lines 
and a cooled 14-bit frame transfer EMCCD C9100-50 camera, 
as described.45 For Pom1 and Cdr2 signal quantifications with 
Cellophane, 5 pictures for each channel were acquired over 30 s 
(1 s exposure time, binning 1).
Images for Figures 1G and 5F and Figure S1E and F 
were acquired as follows: Images for Figures 1G and 5F and 
Figure S1E were taken on a DMRXA2 upright microscope 
(Leica Microsystems), equipped with a 100×/1.4NA oil immer-
sion PlanApo objective and a Coolsnap HQ CCD camera 
(Photometrics), exposure time: 2 s. Images for Figure S1F were 
acquired on a full motorized inverted microscope Nikon Eclipse 
Ti-E microscope equipped with the Perfect Focus System to main-
tain the focus, a 100×/1.45-NA PlanApo oil immersion objective, 
a Mad City Lab piezo stage, a Yokogawa CSUX1 confocal unit a 
Photometrics HQ2 CCD camera and a laser bench (Errol) with 
491-561 nm diode laser, 100 mW each (Cobolt), exposure time 
for GFP, mCherry, or tdTomato: 2s (or 0.5 s for Fig. S4B). Laser 
power 30% (back pupil of the objective: 1.9 mW), binning 2, 
electronic gain 3.
For Figure 5F, Cdr2-mEGFP cortical fluorescence intensity 
was measured along the entire cortex of interphase cells with the 
Linescan tool of Metamorph software (3 pixels width) on single 
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medial focal planes. The graph represents the mean intensity of 
≥60 cells.
Total fluorescence intensity quantifications shown in 
Figure 2E were performed on a sum projection of spinning disk 
confocal z-stacks of an individual cell. For measurement of total 
fluorescence intensity, the polygon tool in ImageJ was used to 
draw a line by hand around the cell and the average fluores-
cence intensity within the cell was obtained using the Analyze < 
Measure tool. The fluorescence intensity measured was corrected 
for both the background fluorescence intensity (measured just 
outside the cell examined) and the fluorescence intensity of an 
untagged cell (acquired and measured for fluorescence intensity 
in the same way as mentioned above).
For quantification of western blots in Figure 2D, 50 µg whole-
cell lysates were loaded on SDS-PAGE and detected by Western 
blotting with α-GFP mAb (1/5000, Roche) and α-tubulin mAb 
(1/10 000, kind gift from Andrea Baines). Bands were selected 
and quantified using the Analyze < Gels < Plot-lanes tool of 
ImageJ. For each strain, a total of 6 lanes were quantified from 2 
independent experiments. The intensity of the α-GFP signal was 
normalized to that of α-tubulin before setting the Pom1-GFP 
signal value to 1.
For cell length measurements, cells were grown at 30 °C in 
EMM supplemented with uracil, adenine, and leucine. Cell 
length measurements were made with Metamorph software on 
DIC images of septating cells taken on the DMRXA2 micro-
scope described above (for Fig. 5G) or on calcofluor-stained cells 
imaged with a DeltaVision setup (for all other measurements), 
as described.46 In all comparisons made, strains with identical 
auxotrophies were used.
Image analysis by Cellophane and data processing
Cellophane is an ImageJ plugin we developed for the quan-
tification of a fluorescent signal at the cell cortex. In the man-
ual mode, the user manually traces the cortex using the ImageJ 
tools. In the automatic mode, fluorescent dextran (Alexa Fluor® 
647 at 0.2 µg final concentration; Invitrogen) is added to the 
medium before imaging and the cell boundaries are automati-
cally extracted using edge detection and a snake algorithm.47 
This provides a higher throughput but a somewhat lower preci-
sion. In this study, we have used the manual mode throughout, 
except for Figure 2B and C. In addition to the fluorescent signal 
at the cell cortex, the plugin also measures the mean cytoplas-
mic and background signals along with their variance, as well 
as the cell length. Those values are printed to a file that can be 
used for further analyses such as profile alignment and averag-
ing. Cellophane is open-source and freely available under a GPL 
licence (http://www.unil.ch/cbg).
Data were aligned and further analyzed using the R software 
(http://www.r-project.org/). As Pom1 gradients are often asym-
metric at the 2 cell ends, we kept this asymmetry, systematically 
orienting the profiles with the higher Pom1 intensity peak on 
the left on all alignments involving Pom1. Cells were pooled in 
bins 2 µm in length, except for Figure 1C, for which 1-µm bins 
were used. Qualitatively similar results were obtained for both 
bin sizes. In all comparison of Cdr2 profiles between wild-type 
and mutant backgrounds, a single bin is shown (Figs. 2B, 3B, 
and 6D). Bins of other cell sizes showed qualitatively similar 
results (similar profiles in wild-type and mutant backgrounds).
To extract Pom1-tdTomato basal domain length, we used a 
threshold below which the length of the domain was measured 
(150 for Fig. 1; 80 for Fig. 4). To extract Cdr2-mEGFP domain 
length and intensity we used a threshold above which the length 
and intensity of the domain were measured (150 for Fig. 1 and 
5; 40 for Fig. 4). The distinct thresholds used were due to dis-
tinct fluorescent values of the images. To measure Cdr2 levels 
in pom1Δ (Fig. 5B), we did not use a threshold, because this 
skewed the data due to the significantly wider spread of Cdr2 
in pom1Δ cells. For the overlap analysis, the mean between the 2 
fluorescence values at the intersection of the Pom1-tdTomato and 
Cdr2-mEGFP curves after smoothing with a Gaussian filter was 
plotted. Qualitatively similar, but noisier results were obtained 
when smoothing was omitted (data not shown).
Statistical analysis
For pairwise comparison of average cell length, the Student t 
test was used. Throughout all figures, significance of this statisti-
cal test is marked with asterisks, with * indicating P < 0.05, **P < 
10-5 and *** P < 10−10. NS, not significant.
Two-sided linear regression tests were performed to assess 
the effect of cell length on Pom1 and Cdr2 domain lengths and 
intensities, except in Figure 4G, where one-sided linear regres-
sion tests were used. Significant P values (all are below 10-5) indi-
cate that the null hypotheses that cell length has no effect on 
Pom1, or Cdr2 domain lengths can be rejected. Thus, Pom1 and 
Cdr2 distributions vary with cell length. The corresponding cor-
relation values are denoted by r.
In order to assess the redundancy of the information contained 
in the Pom1 and Cdr2 profiles, we used an additive linear model 
including the lengths of the Pom1 basal domain x
p
 and area of 
the Cdr2 domain x
c
 for the cell length y
c
 : y
c
 = a
0
 + a
1
x
p
 + a
2
x
c
 + ε, 
where ε is the Gaussian noise. Significant P values for the linear 
regression tests on coefficients a
1
 and a
2
 allow the rejection of the 
null hypothesis that one profile does not provide information on 
cell length in addition to the other profile, suggesting that they 
both contribute additive information
Biochemistry
For bacterial expression and recombinant protein production 
for kinase assays, Cdr2 fragments amplified from pSM788 or the 
mutant plasmids were cloned between BamHI and XhoI sites in 
pGEX-4T-1.
For kinase assays, recombinant Pom1 or Pom1Δ305 and Cdr2 
fragments were obtained as described.18 Kinase assays were per-
formed in 30 mM Tris pH 8, 100 mM NaCl, 10 mM MgCl2, 1 
mM EGTA, 10% glycerol, 1 mM DTT, 20 µM ATP, and 2 µCi 
[32P] ATP (PerkinElmer) in a 15 µl final volume reaction. After a 
30-min incubation at 30 °C, the reaction was stopped by boiling 
in sample buffer and analyzed by SDS–PAGE. 32P-incorporation 
was detected in a phosphorimager. Silver staining was done 
according to the manufacturer’s protocol (Pierce® Silver stain kit) 
to check for equivalent amounts of substrates.
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